FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Raxa Sankreacha

Research Profile

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Brian M Keller; Ananth Ravi; Raxa Sankreacha; Jean-Philippe Pignol
Permanent breast seed implant dosimetry quality assurance.
Gerard Morton; Raxa Sankreacha; Ewa Szumacher; Eric Vigneault; Liying Zhang; Manraj Chahal; Patrick Cheung; Hans T Chung; Cyril Danjoux; Andrea Deabreu; Andrew Loblaw; Alexandre Mamedov; Colvin Springer
Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?
Gerard C Morton; Raxa Sankreacha; Gail Tsang; Liying Zhang; Deidre Batchelar; Patrick Cheung; Hans Chung; Cyril Danjoux; Andrea Deabreu; D Andrew Loblaw; Alexandre Mamedov; Ewa Szumacher
Health-related quality of life after single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for prostate cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Raxa Sankreacha (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Brian M Keller; Ananth Ravi; Raxa Sankreacha; Jean-Philippe Pignol
Permanent breast seed implant dosimetry quality assurance.
International journal of radiation oncology, biology, physics 2012;83(1):84-92.
2011: Gerard Morton; Raxa Sankreacha; Ewa Szumacher; Eric Vigneault; Liying Zhang; Manraj Chahal; Patrick Cheung; Hans T Chung; Cyril Danjoux; Andrea Deabreu; Andrew Loblaw; Alexandre Mamedov; Colvin Springer
Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2011;100(3):463-7.
2011: Gerard C Morton; Raxa Sankreacha; Gail Tsang; Liying Zhang; Deidre Batchelar; Patrick Cheung; Hans Chung; Cyril Danjoux; Andrea Deabreu; D Andrew Loblaw; Alexandre Mamedov; Ewa Szumacher
Health-related quality of life after single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for prostate cancer.
International journal of radiation oncology, biology, physics 2011;80(5):1299-305.
2011: Rick Holly; Niki Law; D Andrew Loblaw; Gerard C Morton; Raxa Sankreacha; Thomas Cisecki; Hans T Chung
Use of cone-beam imaging to correct for catheter displacement in high dose-rate prostate brachytherapy.
Brachytherapy 2011;10(4):299-305.
2010: Gerard Morton; D Andrew Loblaw; Raxa Sankreacha; Andrea Deabreu; Liying Zhang; Alexandre Mamedov; Patrick Cheung; Brian Keller; Cyril Danjoux; Ewa Szumacher; Gillian Thomas
Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life.
International journal of radiation oncology, biology, physics 2010;77(3):811-7.
2009: Jean-Philippe Pignol; Eileen Rakovitch; Brian M Keller; Raxa Sankreacha; Carole Chartier
Tolerance and acceptance results of a palladium-103 permanent breast seed implant Phase I/II study.
International journal of radiation oncology, biology, physics 2009;73(5):1482-8.
2009: Rick Holly; Sten Myrehaug; Asim Kamran; Raxa Sankreacha; Gerard Morton
High-dose-rate prostate brachytherapy in a patient with bilateral hip prostheses planned using megavoltage computed tomography images acquired with a helical tomotherapy unit.
Brachytherapy 2009;8(1):70-3.
2008: Gerard Morton; Raxa Sankreacha; Patrick Halina; Andrew Loblaw
A comparison of anatomy-based inverse planning with simulated annealing and graphical optimization for high-dose-rate prostate brachytherapy.
Brachytherapy 2008;7(1):12-6.
2008: Brian M Keller; Jean-Philippe Pignol; Eileen Rakovitch; Raxa Sankreacha; Peter O'brien
A radiation badge survey for family members living with patients treated with a (103)Pd permanent breast seed implant.
International journal of radiation oncology, biology, physics 2008;70(1):267-71.
2007: Elizabeth A Barnes; Gillian Thomas; Ida Ackerman; Lisa Barbera; D Letourneau; Kelvin Lam; N Makhani; Raxa Sankreacha
Prospective comparison of clinical and computed tomography assessment in detecting uterine perforation with intracavitary brachytherapy for carcinoma of the cervix.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2007;17(4):821-6.
2007: Curtis Caldwell; Raxa Sankreacha; A W Lightstone; Peter O'brien; Cindy Matheson
Contamination during a brachytherapy procedure.
Health physics 2007;92(2 Suppl):S8-S12.
2006: Yongjin Wang; Raxa Sankreacha; Adnan Al-Hebshi; Andrew Loblaw; Gerard Morton
Comparative study of dosimetry between high-dose-rate and permanent prostate implant brachytherapies in patients with prostate adenocarcinoma.
Brachytherapy 2006;5(4):251-5.
2006: Jean-Philippe Pignol; Brian Keller; Eileen Rakovitch; Raxa Sankreacha; Harry Easton; William Que
First report of a permanent breast 103Pd seed implant as adjuvant radiation treatment for early-stage breast cancer.
International journal of radiation oncology, biology, physics 2006;64(1):176-81.
2005: Brian Keller; Raxa Sankreacha; Eileen Rakovitch; Peter O'brien; Jean-Philippe Pignol
A permanent breast seed implant as partial breast radiation therapy for early-stage patients: a comparison of palladium-103 and iodine-125 isotopes based on radiation safety considerations.
International journal of radiation oncology, biology, physics 2005;62(2):358-65.